Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Juli 2007 12:49 ET | Quelle: Penwest Pharmaceuticals Co.

Penwest Announces Allowance for Oxymorphone Patent Application Related to OPANA ER

DANBURY, Conn., July 23, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported that the U.S. Patent and Trademark Office (PTO) has indicated on its website that a Penwest...
17. Juli 2007 16:36 ET | Quelle: Penwest Pharmaceuticals Co.

Penwest Second Quarter 2007 Financial Results Conference Call

DANBURY, Conn., July 17, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, July 27, at 11:00 a.m. EDT to review its financial results for the...
17. Juli 2007 06:45 ET | Quelle: Penwest Pharmaceuticals Co.

Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals

DANBURY, Conn., July 17, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that it has entered into a research, development, commercialization and license agreement...
25. Juni 2007 08:30 ET | Quelle: Penwest Pharmaceuticals Co.

Christophe Bianchi, M.D. Named to Penwest Board of Directors

DANBURY, Conn., June 25, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that Christophe Bianchi, M.D. has been named to the Company's Board of Directors. Dr....

Vorherige Seite